by Jane Schumacher | Aug 12, 2024
Suppliers will need to certify to BSI Kitemark for Minimized Risk of Antimicrobial Resistance (AMR) 12 August 2024 – Pharmaceutical companies bidding for the newly launched NHS Antimicrobial Product subscription model will be required to demonstrate the steps...
by Jane Schumacher | May 7, 2024
The Global AMR Diary to ignite awareness and catalyze action to shape policy and saves lives GENEVA — MAY 7, 2024 — The Partnership to Fight Infectious Disease (PFID) and a collective of influential global health leaders, including public and private...
by Danny O'Keefe | Dec 7, 2023
NeoAMS program targets inappropriate antibiotic use among hospitalized newborns. Geneva – 7 December 2023 – The AMR Industry Alliance, the largest coalition of life sciences companies dedicated to combatting antimicrobial resistance (AMR), today announced that South...
by Danny O'Keefe | Dec 21, 2022
Prize recognizes innovative and scalable stewardship programs in low-to-moderate-income countries. Geneva – December 21, 2022 – The AMR Industry Alliance, the leading life-sciences coalition set up to provide sustainable solutions to curb antimicrobial resistance...
by Luka Srot | Feb 1, 2022
Taking action on AMR: Largest life sciences sector coalition shows leadership in R&D, appropriate use and access to antibiotics and responsible manufacturing Today the AMR Industry Alliance released its latest Progress Report, reflecting on collective...
